These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 26043154

  • 1. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
    Yokoyama R, Miyagawa M, Okayama H, Inoue T, Miki H, Ogimoto A, Higaki J, Mochizuki T.
    Int J Cardiol; 2015 Sep 15; 195():180-7. PubMed ID: 26043154
    [Abstract] [Full Text] [Related]

  • 2. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA, Birnie DH, Klein R, de Kemp RA, Leung E, Renaud J, DaSilva J, Wells GA, Beanlands RS, Nery PB.
    Circ Cardiovasc Imaging; 2013 Sep 15; 6(5):617-26. PubMed ID: 23884290
    [Abstract] [Full Text] [Related]

  • 3. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
    Ito K, Okazaki O, Morooka M, Kubota K, Minamimoto R, Hiroe M.
    Intern Med; 2014 Sep 15; 53(18):2041-9. PubMed ID: 25224185
    [Abstract] [Full Text] [Related]

  • 4. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M.
    J Card Fail; 2015 Apr 15; 21(4):313-22. PubMed ID: 25512195
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B, Agarwal A, Luketich J, Landreneau R, Avril N.
    Nucl Med Commun; 2008 Jul 15; 29(7):614-22. PubMed ID: 18528183
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT.
    Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, Tiemann K, Maintz D, Scheld HH, Schober O, Weckesser M.
    J Nucl Med; 2012 Jun 15; 53(6):856-63. PubMed ID: 22577239
    [Abstract] [Full Text] [Related]

  • 9. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M, Erba P, Volterrani D, Guidoccio F, Lazzeri E, Caramella D, Mariani G.
    AJR Am J Roentgenol; 2011 Jul 15; 197(1):209-16. PubMed ID: 21701032
    [Abstract] [Full Text] [Related]

  • 10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul 15; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 11. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P, Lehtonen J, Kandolin R, Schildt J, Marjasuo S, Miettinen H, Airaksinen J, Vihinen T, Tuohinen S, Haataja P, Kupari M.
    Am J Cardiol; 2015 Nov 15; 116(10):1581-5. PubMed ID: 26411357
    [Abstract] [Full Text] [Related]

  • 12. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.
    J Nucl Med; 2007 Oct 15; 48(10):1662-9. PubMed ID: 17873124
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y, Grant C, Xie K, Sweiss NJ.
    Clin Nucl Med; 2017 Feb 15; 42(2):88-94. PubMed ID: 27922863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R, Zhu H, Chen Y, Li C, Li F, Shen Z, Tian J, Yu L, Xu B.
    Hematol Oncol; 2014 Sep 15; 32(3):126-32. PubMed ID: 23996464
    [Abstract] [Full Text] [Related]

  • 17. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.
    Ann Nucl Med; 2014 Nov 15; 28(9):926-35. PubMed ID: 25107363
    [Abstract] [Full Text] [Related]

  • 18. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.
    JACC Cardiovasc Imaging; 2018 Jan 15; 11(1):94-107. PubMed ID: 28624396
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.
    Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A.
    Ann Nucl Med; 2018 Jun 15; 32(5):319-327. PubMed ID: 29560563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.